Ambrisentan 10 MG Oral Tablet — RxCUI 722116
RxNorm drug concept · Semantic clinical drug
RxCUI 722116
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
59 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI722116
Official nameAmbrisentan 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped59
Reported Medicaid activity (SDUD)21,600 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ambrisentan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ambrisentan won't cure PAH, but it can make a real difference in how you feel and function. It works by blocking a protein called ET-1 that causes the blood vessels in your lungs t...
- What exactly does ambrisentan do, and will it cure my PAH?
- Good news — food doesn't affect how well your body absorbs ambrisentan, so you can take it with or without a meal, whichever works best for your routine. Pick a time of day you can...
- Can I take ambrisentan with food, and does it matter what time of day I take it?
🕸️ Concept Web — How Ambrisentan 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ambrisentan 10 MG Oral Tablet
RxCUI 722116 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ambrisentan
358274IN
-
Ambrisentan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Letairis
722117BN
-
Letairis
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ambrisentan Oral Tablet
722115SCDF -
Ambrisentan Oral Product
1157135SCDG -
Ambrisentan Pill
1157136SCDG -
Ambrisentan Oral Tablet [Letairis]
722119SBDF -
Letairis Oral Product
1166063SBDG -
Letairis Pill
1166064SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ambrisentan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ambrisentan 10 MG
722114SCDC -
Ambrisentan 10 MG Oral Tablet [Letairis]
722120SBD -
Ambrisentan 10 MG [Letairis]
722118SBDC
-
Ambrisentan 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ambrisentan 10 MG
SCDC · 722114 -
Ambrisentan Oral Tablet
SCDF · 722115 -
Ambrisentan Oral Product
SCDG · 1157135 -
Ambrisentan Pill
SCDG · 1157136
Brand-Name Concepts
-
Ambrisentan 10 MG Oral Tablet [Letairis]
SBD · 722120 -
Ambrisentan 10 MG [Letairis]
SBDC · 722118 -
Ambrisentan Oral Tablet [Letairis]
SBDF · 722119 -
Letairis Oral Product
SBDG · 1166063 -
Letairis Pill
SBDG · 1166064 -
Letairis
BN · 722117
📦 FDA Products & Package NDCs
25 products · 59 package NDCs
59 package NDCs map to RxCUI 722116 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-4270-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4270-93) | Ambrisentan | Mylan Pharmaceuticals Inc. | 2019-04-29 |
| 00378-4271-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4271-93) | Ambrisentan | Mylan Pharmaceuticals Inc. | 2019-04-29 |
| 00591-2405-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0591-2405-30) | Ambrisentan | Actavis Pharma, Inc. | 2019-04-30 |
| 00591-2406-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0591-2406-30) | Ambrisentan | Actavis Pharma, Inc. | 2019-04-30 |
| 42794-0051-08 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-051-08) | AMBRISENTAN | Sigmapharm Laboratories, LLC | 2019-04-10 |
| 42794-0051-22 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-051-22) | AMBRISENTAN | Sigmapharm Laboratories, LLC | 2019-04-10 |
| 42794-0052-08 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-052-08) | AMBRISENTAN | Sigmapharm Laboratories, LLC | 2019-04-10 |
| 42794-0052-22 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-052-22) | AMBRISENTAN | Sigmapharm Laboratories, LLC | 2019-04-10 |
| 47335-0236-64 | 3 BLISTER PACK in 1 CARTON (47335-236-64) / 10 TABLET, FILM... | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0236-66 | 1 BLISTER PACK in 1 CARTON (47335-236-66) / 10 TABLET, FILM... | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0236-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-236-83) | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0236-85 | 10 TABLET, FILM COATED in 1 BOTTLE (47335-236-85) | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0237-64 | 3 BLISTER PACK in 1 CARTON (47335-237-64) / 10 TABLET, FILM... | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0237-66 | 1 BLISTER PACK in 1 CARTON (47335-237-66) / 10 TABLET, FILM... | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0237-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-237-83) | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 47335-0237-85 | 10 TABLET, FILM COATED in 1 BOTTLE (47335-237-85) | ambrisentan | Sun Pharmaceutical Industries, Inc. | 2019-04-29 |
| 50090-7670-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-7670-0) | ambrisentan | A-S Medication Solutions | 2025-10-07 |
| 51407-0594-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-594-30) | Ambrisentan | Golden State Medical Supply, Inc. | 2025-11-17 |
| 51407-0595-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-595-30) | Ambrisentan | Golden State Medical Supply, Inc. | 2025-11-17 |
| 59651-0494-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-494-30) | ambrisentan | Aurobindo Pharma Limited | 2022-07-21 |
| 59651-0495-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-495-30) | ambrisentan | Aurobindo Pharma Limited | 2022-07-21 |
| 60505-4552-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-4552-3) | Ambrisentan | Apotex Corp. | 2022-09-19 |
| 60505-4553-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-4553-3) | Ambrisentan | Apotex Corp. | 2022-09-19 |
| 61958-0801-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-1) | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0801-02 | 3 BLISTER PACK in 1 CARTON (61958-0801-2) / 10 TABLET, FILM... | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0801-03 | 1 BLISTER PACK in 1 CARTON (61958-0801-3) / 10 TABLET, FILM... | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0801-04 | 1 BLISTER PACK in 1 CARTON (61958-0801-4) / 10 TABLET, FILM... | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0801-05 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-5) | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0801-06 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-6) | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0802-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0802-1) | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0802-02 | 3 BLISTER PACK in 1 CARTON (61958-0802-2) / 10 TABLET, FILM... | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0802-03 | 1 BLISTER PACK in 1 CARTON (61958-0802-3) / 10 TABLET, FILM... | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 61958-0802-05 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0802-5) | Letairis | Gilead Sciences, Inc. | 2007-06-15 |
| 69097-0386-02 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-386-02) | Ambrisentan | Cipla USA Inc. | 2019-04-26 |
| 69097-0386-19 | 1 BLISTER PACK in 1 CARTON (69097-386-19) / 10 TABLET, FILM... | Ambrisentan | Cipla USA Inc. | 2019-04-26 |
| 69097-0387-02 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-387-02) | Ambrisentan | Cipla USA Inc. | 2019-04-26 |
| 69097-0387-19 | 1 BLISTER PACK in 1 CARTON (69097-387-19) / 10 TABLET, FILM... | Ambrisentan | Cipla USA Inc. | 2019-04-26 |
| 70710-1179-01 | 100 TABLET, FILM COATED in 1 BOTTLE (70710-1179-1) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1179-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1179-3) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1179-07 | 1 BLISTER PACK in 1 CARTON (70710-1179-7) / 10 TABLET, FILM... | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1179-08 | 3 BLISTER PACK in 1 CARTON (70710-1179-8) / 10 TABLET, FILM... | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1179-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1179-9) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1180-01 | 100 TABLET, FILM COATED in 1 BOTTLE (70710-1180-1) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1180-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1180-3) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1180-07 | 1 BLISTER PACK in 1 CARTON (70710-1180-7) / 10 TABLET, FILM... | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1180-08 | 3 BLISTER PACK in 1 CARTON (70710-1180-8) / 10 TABLET, FILM... | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70710-1180-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1180-9) | Ambrisentan | Zydus Pharmaceuticals USA Inc. | 2019-04-12 |
| 70771-1363-01 | 100 TABLET, FILM COATED in 1 BOTTLE (70771-1363-1) | Ambrisentan | Zydus Lifesciences Limited | 2019-04-12 |
| 70771-1363-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1363-3) | Ambrisentan | Zydus Lifesciences Limited | 2019-04-12 |
| 70771-1363-07 | 1 BLISTER PACK in 1 CARTON (70771-1363-7) / 10 TABLET, FILM... | Ambrisentan | Zydus Lifesciences Limited | 2019-04-12 |
Observed labelers:
Gilead Sciences, Inc. (10) ·
Zydus Lifesciences Limited (10) ·
Zydus Pharmaceuticals USA Inc. (10) ·
Sun Pharmaceutical Industries, Inc. (8) ·
Cipla USA Inc. (4) ·
Sigmapharm Laboratories, LLC (4)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.